Actuate Therapeutics, Inc. (NASDAQ:ACTU) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jason Keyes Other companies: BlossomHill Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 6, 2026); Sesen Bio Inc (Director · May 3, 2021 – Jun 22, 2022 · Past); Equillium, Inc. (Chief Financial Officer · Dec 10, 2020 – Feb 14, 2025 · Past) | Director · Since at least Aug 12, 2024 |
| Leslie W Kreis Other companies: Cognition Therapeutics, Inc. (Director · Since at least Jun 10, 2022); IN8bio, Inc. (Director · Aug 16, 2022 – Dec 12, 2022 · Past); Lantern Pharma Inc. (Director · Jun 10, 2020 – Mar 17, 2022 · Past) | Director · Since at least Jun 27, 2025 |
| Martin H Huber Jr Other companies: Syndax Pharmaceuticals, Inc. (Director · Since at least Sep 15, 2021); Mersana Therapeutics Inc (President, CEO, Director · Since at least Jan 15, 2021); Xilio Therapeutics, Inc. (PRESIDENT AND HEAD OF R&D · Oct 21, 2021 – Aug 16, 2023 · Past) | Director · Since at least May 1, 2026 |
| Todd Thomson Other companies: ZOOZ Strategy Ltd. (Director · Since at least Mar 18, 2026); Dragonfly Energy Holdings Corp (Director · Aug 10, 2021 – Aug 10, 2021 · Past); Cordia Bancorp Inc (Director · Mar 29, 2013 – Aug 31, 2016 · Past) | Director · Since at least Aug 12, 2024 |
| Roger Sawhney Other companies: Adlai Nortye Group Ltd. (Director · Since at least Mar 18, 2026); Arbutus Biopharma Corporation (Director · Since at least Aug 4, 2025) | Director · Since at least May 22, 2025 |
| Aaron G.L. Fletcher Other companies: Cognition Therapeutics, Inc. (Director · Since at least Jun 18, 2025) | Director · Since at least May 22, 2025 |
| Amy Ronneberg Other companies: Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past) | Director · Since at least Aug 12, 2024 |
| Dan Zabrowksi Other companies: Apexigen Inc. (Director · Jul 29, 2022 – Aug 23, 2023 · Past) | Director · Since at least Aug 12, 2024 |
| Andrew Paul Mazar | Chief Operating Officer · Since at least Apr 1, 2025 |
| Daniel M. Schmitt | President, CEO and Director, Director · Since at least Apr 1, 2025 |
| Daniel Zabrowski | Director · Since at least Nov 4, 2026 |
| Martin Huber | Director · Since May 6, 2026 |
| Paul J Lytle | Chief Financial Officer · Since at least Apr 1, 2025 |